EP3078667

THE UNITED STATES OF AMERICA
Application Number
EP16157001A
Filing Date
Jan 25, 2002
Status
Granted And Under Opposition
Oct 19, 2018
Grant Date
Nov 21, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP3078667B1 was granted to The United States OF America on Nov 21, 2018 following the initial filing on Jan 25, 2002 under the application number EP16157001A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (11)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKAug 21, 2019ADMISSIBLE
ACCORD HEALTHCAREAug 20, 2019ADMISSIBLE
DR REDDYS LABORATORIES BETAPHARM ARZNEIMITTELAug 20, 2019ADMISSIBLE
ZENTIVA KSAug 20, 2019ADMISSIBLE
KRKAAug 20, 2019WITHDRAWN
PENTAFARMAAug 19, 2019ADMISSIBLE
SYNTHONAug 16, 2019ADMISSIBLE
LEK PHARMACEUTICALS DDAug 14, 2019WITHDRAWN
PFIZERAug 7, 2019ADMISSIBLE
FRESENIUS KABI DEUTSCHLANDJun 17, 2019ADMISSIBLE
TEVA PHARMACEUTICALSMay 29, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents